Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy

Abstract

Indoleamine 2,3 dioxygenase (IDO) activity during pregnancy protects developing fetuses from maternal immune responses in CBA mice. We show here that fetal allografts were rejected only in mating combinations where paternally inherited tissue antigens elicited potent maternal T cell responses after exposure to IDO inhibitor. IDO inhibitor treatment triggered extensive inflammation at the maternal-fetal interface in susceptible mating combinations, which was characterized by complement deposition and hemorrhagic necrosis. Identical inflammatory responses occurred in B cell–deficient (RAG-1−/−) mothers that carried a monoclonal cohort of CD8+ T cells specific for a single paternally inherited fetal major histocompatibility complex antigen. Thus, fetal allograft rejection was accompanied by a unique form of inflammation that was characterized by T cell–dependent, antibody-independent activation of complement. In contrast, no inflammation, complement deposition or T cell infiltration was elicited when mice carrying syngeneic fetuses were exposed to IDO inhibitor. These data show that IDO activity protects the fetus by suppressing T cell–driven local inflammatory responses to fetal alloantigens.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Detection of C3 and Crry in decidua.
Figure 2: T cell infiltration and complement deposition at the maternal-fetal interface in B cell–deficient mice treated with IDO inhibitor.

References

  1. Mellor, A. L. & Munn, D. H. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18, 367–391 (2000).

    CAS  Article  Google Scholar 

  2. Brent, L. in A History of Transplantation Immunology, 403– 419 (Academic Press, London, 1997).

    Book  Google Scholar 

  3. Hagmann, M. Embryos attacked by mom's natural defenses. Science 287, 408 (2000).

    CAS  Article  Google Scholar 

  4. Medawar, P. B. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7, 320–328 (1953).

    Google Scholar 

  5. Tafuri, A., Alferink, J., Moller, P., Hammerling, G. J. & Arnold, B. T cell awareness of paternal alloantigens during pregnancy . Science 270, 630–633 (1995).

    CAS  Article  Google Scholar 

  6. Jiang, S. P. & Vacchio, M. S. Multiple mechanisms of peripheral T cell tolerance to the fetal “allograft”. J. Immunol. 160, 3086–3090 ( 1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhou, M. & Mellor, A. L. Expanded cohorts of maternal CD8+ T cells specific for paternal MHC class I accumulate during pregnancy . J. Reprod. Immunol. 40, 47– 62 (1998).

    CAS  Article  Google Scholar 

  8. Lambert, N. C. et al. Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164, 5545–5548 (2000).

    CAS  Article  Google Scholar 

  9. Munn, D. H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism . Science 281, 1191–1193 (1998).

    CAS  Article  Google Scholar 

  10. Cady, S. G. & Sono, M. 1-methyl-DL-tryptophan, β-(3-Benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291, 326–333 (1991).

    CAS  Article  Google Scholar 

  11. Yeoman, H. & Mellor, A. L. Tolerance and MHC restriction in transgenic mice expressing an MHC class I gene in erythroid cells. Int. Immunol. 4, 59–65 ( 1992).

    CAS  Article  Google Scholar 

  12. Klein, J. Biology of the Mouse Histocompability-2 Complex (Springer-Verlag, New York, 1975).

    Book  Google Scholar 

  13. Xu, C. et al. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287, 498– 501 (2000).

    CAS  Article  Google Scholar 

  14. Munn, D. H. et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363– 1372 (1999).

    CAS  Article  Google Scholar 

  15. Schwaeble, W. J. & Reid, K. B. Does properdin crosslink the cellular and the humoral immune response? Immunol. Today 20, 17–21 ( 1999).

    CAS  Article  Google Scholar 

  16. Billingham, R. E. & Medawar, P. B. The technique of free skin grafting in mammals. J. Exp. Biol. 28, 385–401 (1951).

    Google Scholar 

Download references

Acknowledgements

We thank D. McCool for technical assistance, A. Compton for administrative support and M. Litaker for statistical analysis. Supported by National Institutes of Health grants AI44219 to (A. L. M.), HL60137 (to D. H. M.) and AI40576 and AI44912 (to H. M.), the Medical College of Georgia Department of Medicine and the Carlos and Marguerite Mason Trust.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrew L. Mellor.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mellor, A., Sivakumar, J., Chandler, P. et al. Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2, 64–68 (2001). https://doi.org/10.1038/83183

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/83183

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing